Loading clinical trials...
Loading clinical trials...
Phase I/II Intra-patient Dose Escalation Study of Vorinostat in Children With Relapsed Solid Tumor, Lymphoma or Leukemia
Conditions
Interventions
zolinza/vorinostat
Locations
10
Germany
Clinic for Pediatric Oncology, Hematology, Immunology and Clinical Cooperation Unit Pediatric Oncology
Heidelberg, Baden-Wurttemberg, Germany
Childrens's Hospital, Pediatric Oncology and Hematology
Augsburg, Germany
Prof. Hess Childrens's Hospital, Pediatric Oncology and Hematology
Bremen, Germany
University Children's Hospital, Pediatric Oncology and Hematology
Cologne, Germany
University Childrens's Hospital, Pediatric Oncology and Hematology
Essen, Germany
University Children's Hospital, Clinic IV
Freiburg im Breisgau, Germany
Start Date
March 1, 2012
Primary Completion Date
March 24, 2017
Completion Date
March 24, 2017
Last Updated
April 11, 2018
Lead Sponsor
National Center for Tumor Diseases, Heidelberg
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions